FIELD: medicine.
SUBSTANCE: technique involves a genetic analysis of the Vall58Met polymorphism of catechol-O-methyl-transferase gene; pre-stimulation suppression and a baseline latent period of acoustic startle are selectively assessed in Met/Met haplotype carriers. If the pre-stimulation suppression tends to decrease with increasing the baseline latent period of acoustic startle, schizophrenia is diagnosed.
EFFECT: higher diagnostic accuracy.
2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETECTION AND DIFFERENTIAL DIAGNOSIS OF SCHIZOPHRENIA FROM PERSONALITY DISORDERS | 2017 |
|
RU2670668C9 |
| METHOD FOR DIAGNOSING A PREDISPOSITION TOWARDS IMPULSIVE AGGRESSIVE BEHAVIOR IN MENTALLY HEALTHY PERSONS | 2020 |
|
RU2744353C1 |
| METHOD OF PREDICTION OF STABILITY LIMIT OF ANIMALS TO SEVERE HYPOXIA AFTER HYPOXIC PRECONDITIONING | 2014 |
|
RU2571603C1 |
| DERIVATIVES OF 5H-DIBENZO[b, e][1, 4]DIAZEPINE AND ITS APPLICATION | 2010 |
|
RU2441867C2 |
| METHOD FOR PREDICTING THE DEGREE OF RISK OF EXTRAPYRAMID SIDE EFFECTS DURING THE BACKGROUND OF HALOPERIDOL THERAPY IN PATIENTS WITH SCHIZOPHRENIC SPECTRUM DISORDERS | 2021 |
|
RU2771180C1 |
| DERIVATIVES OF 7-FLUORO-8-CHLORO-5H-DIBENZO [B, E] [1, 4] DIAZEPINE AND THEIR APPLICATION | 2014 |
|
RU2610169C2 |
| METHOD OF PROFESSIONAL SELECTION OF EMPLOYEES OF POWER DEPARTMENTS AND PERSONS WHOSE ACTIVITIES ARE ASSOCIATED WITH HIGH RISK TO LIFE AND HEALTH, FOR EFFECTIVE PERFORMANCE OF SERVICE ACTIVITIES IN EXTREME CONDITIONS | 2019 |
|
RU2741342C1 |
| METHOD FOR PREDICTING FUNCTIONAL RESULT IN PATIENTS WITH SCHIZOPHRENIA | 2021 |
|
RU2757728C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF FUNCTIONAL MENTAL DISORDERS | 2016 |
|
RU2667954C2 |
| METHOD FOR ANALYSING GENETIC POLYMORPHISM FOR DETERMINING DISPOSITION TO SCHIZOPHRENIA AND ALCOHOLISM | 2012 |
|
RU2565036C2 |
